Altasciences

Owned by Novo Holdings, Altasciences is an integrated drug development solution company offering pharmaceutical and biotechnology companies of all sizes a proven, flexible approach to their preclinical and clinical study needs. Headquartered in Canada, Altasciences has 9 research facilities across North America.

Altasciences’ full-service solutions include preclinical safety testing, bioanalysis, clinical pharmacology, program management, medical writing, biostatistics, and data management, all of which can be tailored to specific sponsor requirements.

Specific to preclinical research services, Altasciences' expertise spans a wide range of non-GLP and GLP CTA/IND-enabling in vivo safety assessment solutions in both rodent and non-rodent species to thoroughly evaluate pharmaceuticals, biologics, animal health products, agrochemicals, and biocides.

Our scientific and regulatory teams work with you to develop customised research programmes and to ensure that your IND/NDA-enabling toxicology, safety pharmacology, and laboratory studies comply with global regulations.

From lead candidate selection to clinical proof of concept, we offer one-stop integrated formulation, preclinical and clinical manufacturing, and analytical services.